Evidence map›Paper›PMID 33173098›Full record

ArticleScientific reports2020

Opioid agonist and antagonist use and the gut microbiota: associations among people in addiction treatment.

Rachel E Gicquelais, Amy S B Bohnert, Laura Thomas, Betsy Foxman

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. The role of morphine- and fentanyl-induced impairment of intestinal epithelial antibacterial activity in dysbiosis and its impact on the microbiota-gut-brain axis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Rachel E GicquelaisUniversity of Wisconsin-Madison School of Nursing, 701 Highland Avenue, Madison, WI, 53705, USA. gicquelais@wisc.edu.ORCID 0000-0002-7022-6385
Amy S B BohnertDepartment of Psychiatry, University of Michigan Medical School, 2800 Plymouth Rd, Ann Arbor, MI, 48109, USA.
Laura ThomasDepartment of Psychiatry, University of Michigan Medical School, 2800 Plymouth Rd, Ann Arbor, MI, 48109, USA.
Betsy FoxmanDepartment of Epidemiology, University of Michigan Medical School, 1415 Washington Heights, Ann Arbor, MI, 48109, USA. bfoxman@umich.edu.ORCID 0000-0001-6682-238X
University of Michigan · USUniversity of Wisconsin–Madison · US

Funding

Johns Hopkins HIV Epidemiology and Prevention Sciences Training ProgramT32AI102623 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Shruti H Mehta · 2013 to 2026
$5.3M
Developing a Prescription Opioid Overdose Prevention InterventionR34DA035331 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOHNERT, AMY S B · 2014 to 2016
$672k
NIAID NIH HHS T32 AI102623NIDA NIH HHS R34 DA035331
6 · The paper itself

Abstract

Murine models suggest that opioids alter the gut microbiota, which may impact opioid tolerance and psychopathology. We examined how gut microbiota characteristics related to use of opioid agonists and antagonists among people receiving outpatient addiction treatment. Patients (n = 46) collected stool samples and were grouped by use of opioid agonists (heroin, prescription opioids), antagonists (naltrexone), agonist-antagonist combinations (buprenorphine-naloxone), or neither agonists nor antagonists within the month before enrollment. We sequenced the V4 region of the 16S rRNA gene using Illumina MiSeq to examine how alpha diversity, enterotypes, and relative abundance of bacterial genera varied by opioid agonist and antagonist exposures. Compared to 31 participants who used neither agonists nor antagonists, 5 participants who used opioid agonists (without antagonists) had lower microbiota diversity, Bacteroides enterotypes, and lower relative abundance of Roseburia, a butyrate producing genus, and Bilophila, a bile acid metabolizing genus. There were no differences in gut microbiota features between those using agonist + antagonists (n = 4), antagonists only (n = 6), and neither agonists nor antagonists. Similar to murine morphine exposure models, opioid agonist use was associated with lower microbiota diversity. Lower abundance of Roseburia and Bilophila may relate to the gut inflammation/permeability and dysregulated bile acid metabolism observed in opioid-exposed mice.

Indexed as

AdultAnalgesics, OpioidBacteriaBacteroidesBilophilaBuprenorphineFecesFemaleGastrointestinal MicrobiomeHumansMaleMiddle AgedNaltrexoneNarcotic AntagonistsOpioid-Related DisordersPopulation DynamicsAnalgesics, OpioidBuprenorphineNaltrexoneNarcotic AntagonistsRNA, Ribosomal, 16S

Identifiers

PMID33173098
PMCPMC7655955
OpenAlexW3105672003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.